These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8093350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL, Zhou YZ, Butel JS.
    Cancer Res; 1991 Jan 01; 51(1):49-54. PubMed ID: 1670994
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y, Hayashi K, Hirohashi S, Sekiya T.
    Cancer Res; 1991 Oct 15; 51(20):5520-5. PubMed ID: 1655254
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S, Chou MJ, Lee CS, Shih C.
    Oncogene; 1993 Feb 15; 8(2):491-6. PubMed ID: 8093978
    [Abstract] [Full Text] [Related]

  • 11. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
    Wang G, Huang CH, Zhao Y, Cai L, Wang Y, Xiu SJ, Jiang ZW, Yang S, Zhao T, Huang W, Gu JR.
    Cell Res; 2000 Dec 15; 10(4):311-23. PubMed ID: 11191353
    [Abstract] [Full Text] [Related]

  • 12. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS.
    Cancer Res; 1994 Jan 01; 54(1):281-5. PubMed ID: 7903205
    [Abstract] [Full Text] [Related]

  • 13. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM.
    Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p53 mutations in human lung tumors.
    Miller CW, Simon K, Aslo A, Kok K, Yokota J, Buys CH, Terada M, Koeffler HP.
    Cancer Res; 1992 Apr 01; 52(7):1695-8. PubMed ID: 1312896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.